ArticleOncotarget2020

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer.

Thomas M Cardillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.